70.95 USD
-0.54 (-0.76%)
Taking everything into account, RDNT scores 3 out of 10 in our fundamental rating. RDNT was compared to 101 industry peers in the Health Care Providers & Services industry. While RDNT is still in line with the averages on profitability rating, there are concerns on its financial health. RDNT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year RDNT was profitable.
In the past year RDNT had a positive cash flow from operations.
Of the past 5 years RDNT 4 years were profitable.
In the past 5 years RDNT always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -0.35%, RDNT perfoms like the industry average, outperforming 47.52% of the companies in the same industry.
RDNT's Return On Equity of -1.20% is in line compared to the rest of the industry. RDNT outperforms 51.49% of its industry peers.
The Return On Invested Capital of RDNT (2.08%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for RDNT is significantly below the industry average of 9.58%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| ROIC | 2.08% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
In the last couple of years the Profit Margin of RDNT has declined.
With a Operating Margin value of 3.96%, RDNT perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
RDNT's Gross Margin of 21.33% is in line compared to the rest of the industry. RDNT outperforms 46.53% of its industry peers.
In the last couple of years the Gross Margin of RDNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.96% | ||
| PM (TTM) | N/A | ||
| GM | 21.33% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RDNT is destroying value.
The number of shares outstanding for RDNT remains at a similar level compared to 1 year ago.
RDNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RDNT has a worse debt to assets ratio.
2.2 Solvency
RDNT has an Altman-Z score of 2.01. This is not the best score and indicates that RDNT is in the grey zone with still only limited risk for bankruptcy at the moment.
RDNT's Altman-Z score of 2.01 is in line compared to the rest of the industry. RDNT outperforms 43.56% of its industry peers.
RDNT has a debt to FCF ratio of 21.06. This is a negative value and a sign of low solvency as RDNT would need 21.06 years to pay back of all of its debts.
The Debt to FCF ratio of RDNT (21.06) is worse than 60.40% of its industry peers.
RDNT has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RDNT (1.01) is worse than 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | 21.06 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.22
WACC9.3%
2.3 Liquidity
A Current Ratio of 1.87 indicates that RDNT should not have too much problems paying its short term obligations.
RDNT has a better Current ratio (1.87) than 74.26% of its industry peers.
RDNT has a Quick Ratio of 1.87. This is a normal value and indicates that RDNT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.87, RDNT is doing good in the industry, outperforming 78.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
The earnings per share for RDNT have decreased strongly by -37.70% in the last year.
RDNT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.79% yearly.
The Revenue has grown by 11.09% in the past year. This is quite good.
RDNT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.65% yearly.
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
3.2 Future
Based on estimates for the next years, RDNT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.27% on average per year.
The Revenue is expected to grow by 10.97% on average over the next years. This is quite good.
EPS Next Y-44.72%
EPS Next 2Y12.26%
EPS Next 3Y16.93%
EPS Next 5Y19.27%
Revenue Next Year10.36%
Revenue Next 2Y10.56%
Revenue Next 3Y9.91%
Revenue Next 5Y10.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RDNT is valuated quite expensively with a Price/Earnings ratio of 186.71.
Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of RDNT to the average of the S&P500 Index (26.77), we can say RDNT is valued expensively.
The Price/Forward Earnings ratio is 89.37, which means the current valuation is very expensive for RDNT.
RDNT's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, RDNT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 186.71 | ||
| Fwd PE | 89.37 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as RDNT.
The rest of the industry has a similar Price/Free Cash Flow ratio as RDNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 105.15 | ||
| EV/EBITDA | 32.31 |
4.3 Compensation for Growth
A more expensive valuation may be justified as RDNT's earnings are expected to grow with 16.93% in the coming years.
PEG (NY)N/A
PEG (5Y)11.12
EPS Next 2Y12.26%
EPS Next 3Y16.93%
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:RDNT (12/31/2025, 3:08:55 PM)
70.95
-0.54 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.04%
Inst Owner Change6.22%
Ins Owners13.02%
Ins Owner Change-0.75%
Market Cap5.47B
Revenue(TTM)1.97B
Net Income(TTM)-12.71M
Analysts86.15
Price Target93.55 (31.85%)
Short Float %12.08%
Short Ratio8.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)40.87%
Min EPS beat(2)-12.24%
Max EPS beat(2)93.99%
EPS beat(4)2
Avg EPS beat(4)-18.47%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)5
Avg EPS beat(8)155.06%
EPS beat(12)7
Avg EPS beat(12)122.76%
EPS beat(16)8
Avg EPS beat(16)-190.67%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)3.68%
Revenue beat(4)3
Avg Revenue beat(4)2.28%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)2%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)12
Avg Revenue beat(16)1.41%
PT rev (1m)8.63%
PT rev (3m)18.45%
EPS NQ rev (1m)-13.82%
EPS NQ rev (3m)-16.32%
EPS NY rev (1m)-15.17%
EPS NY rev (3m)-9.25%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.64%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 186.71 | ||
| Fwd PE | 89.37 | ||
| P/S | 2.78 | ||
| P/FCF | 105.15 | ||
| P/OCF | 21.28 | ||
| P/B | 5.17 | ||
| P/tB | 51.59 | ||
| EV/EBITDA | 32.31 |
EPS(TTM)0.38
EY0.54%
EPS(NY)0.79
Fwd EY1.12%
FCF(TTM)0.67
FCFY0.95%
OCF(TTM)3.33
OCFY4.7%
SpS25.53
BVpS13.72
TBVpS1.38
PEG (NY)N/A
PEG (5Y)11.12
Graham Number10.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| ROCE | 2.52% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.81% | ||
| ROICexgc | 4.81% | ||
| OM | 3.96% | ||
| PM (TTM) | N/A | ||
| GM | 21.33% | ||
| FCFM | 2.64% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexgc growth 3Y-3.51%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score3
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | 21.06 | ||
| Debt/EBITDA | 5.96 | ||
| Cap/Depr | 201.55% | ||
| Cap/Sales | 10.41% | ||
| Interest Coverage | 0.9 | ||
| Cash Conversion | 143.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.01 |
F-Score3
WACC9.3%
ROIC/WACC0.22
Cap/Depr(3y)125.7%
Cap/Depr(5y)126.7%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
EPS Next Y-44.72%
EPS Next 2Y12.26%
EPS Next 3Y16.93%
EPS Next 5Y19.27%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
Revenue Next Year10.36%
Revenue Next 2Y10.56%
Revenue Next 3Y9.91%
Revenue Next 5Y10.97%
EBIT growth 1Y-30.9%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year117.88%
EBIT Next 3Y43.07%
EBIT Next 5Y34.69%
FCF growth 1Y85.26%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y38.64%
OCF growth 3Y15.95%
OCF growth 5Y17.44%
RADNET INC / RDNT FAQ
Can you provide the ChartMill fundamental rating for RADNET INC?
ChartMill assigns a fundamental rating of 3 / 10 to RDNT.
What is the valuation status of RADNET INC (RDNT) stock?
ChartMill assigns a valuation rating of 1 / 10 to RADNET INC (RDNT). This can be considered as Overvalued.
How profitable is RADNET INC (RDNT) stock?
RADNET INC (RDNT) has a profitability rating of 4 / 10.
What is the earnings growth outlook for RADNET INC?
The Earnings per Share (EPS) of RADNET INC (RDNT) is expected to decline by -44.72% in the next year.